NASDAQ: CAMP
Camp4 Therapeutics Corp Earnings Dates, Reports, Calls

Camp4 Therapeutics earnings were -$51.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CAMP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$13.3M, down 1.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CAMP reported annual earnings of -$51.8M, with 5.1% growth.

CAMP earnings history

Current Revenue
$652.0k
Current Earnings
-$51.8M
Current Profit Margin
-7,943.4%

CAMP Return on Equity

Insufficient data to display

CAMP undefined

Current Company
-77.7%
Current Industry
-0.4%
CAMP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CAMP announces earnings.

CAMP undefined

Current Company
-75.38%
Current Industry
5.9%

CAMP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CAMP-$48.35M-$51.79MN/A-$11.04
BLUE-$132.59M-$240.72MN/A-$24.84
CLLS$4.70M-$36.76MN/A-$0.41
COEP-$8.38M-$9.81MN/A-$5.65
ANTX-$51.32M-$51.32MN/A-$1.72

Camp4 Therapeutics Earnings Reports & History FAQ

What were Camp4 Therapeutics's earnings last quarter?

Camp4 Therapeutics (NASDAQ: CAMP) reported Q4 2024 earnings per share (EPS) of $65.46, up 316.9% year over year. Total CAMP earnings for the quarter were -$13.28 million. In the same quarter last year, Camp4 Therapeutics's earnings per share (EPS) was -$30.18.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.

Is Camp4 Therapeutics profitable or losing money?

As of the last Camp4 Therapeutics earnings report, Camp4 Therapeutics is currently losing money. Camp4 Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$51.79 million, a 5.07% increase year over year.

What was CAMP's earnings growth in the past year?

As of Camp4 Therapeutics's earnings date in Q2 2025, Camp4 Therapeutics's earnings has grown year over year. CAMP earnings in the past year totalled -$51.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.